(19/03/2023)vs
HEALTHCARE | 00 | 23 | 1 / 250% | 11 / 1668.8% | 0 / 00% | 11 / 1668.8% | | 1 | 10 | 2 | 12 | 4 | 1 | 1 | 2 | 33 |
(12/03/2023)vs
ΑΜΥΝΤΑΣ BC | 00 | 22 | 2 / 366.7% | 10 / 1566.7% | 0 / 00% | 10 / 1566.7% | | 2 | 7 | 4 | 11 | 0 | 1 | 0 | 2 | 26 |
(19/02/2023)vs
SALFO | 00 | 21 | 3 / 475% | 9 / 1656.3% | 0 / 10% | 9 / 1752.9% | | 4 | 6 | 5 | 11 | 5 | 3 | 0 | 0 | 31 |
(12/02/2023)vs
NEW MED | 00 | 16 | 2 / 633.3% | 7 / 1450% | 0 / 10% | 7 / 1546.7% | | 4 | 4 | 8 | 12 | 3 | 1 | 0 | 2 | 18 |
(29/01/2023)vs
ΑΣΤΡΟΝ ΧΗΜΙΚΑ | 28 | 17 | 0 / 50% | 7 / 977.8% | 1 / 1100% | 8 / 1080% | | 3 | 2 | 5 | 7 | 1 | 4 | 0 | 2 | 20 |
(15/01/2023)vs
HEALTHCARE | 32 | 10 | 0 / 20% | 5 / 1050% | 0 / 00% | 5 / 1050% | | 2 | 2 | 0 | 2 | 3 | 1 | 0 | 2 | 7 |
(08/01/2023)vs
ΙΑΤΡΙΚΗ ΔΙΑΓΝΩΣΗ ΣΑΛΒΑΡΑ | 00 | 20 | 2 / 2100% | 9 / 1369.2% | 0 / 00% | 9 / 1369.2% | | 3 | 3 | 4 | 7 | 0 | 4 | 0 | 1 | 26 |
(18/12/2022)vs
ΑΜΥΝΤΑΣ BC | 28 | 13 | 3 / 650% | 5 / 1435.7% | 0 / 00% | 5 / 1435.7% | | 4 | 3 | 0 | 3 | 2 | 3 | 0 | 2 | 7 |
(06/11/2022)vs
ΑΣΤΡΟΝ ΧΗΜΙΚΑ | 36 | 16 | 2 / 540% | 7 / 1070% | 0 / 00% | 7 / 1070% | | 3 | 8 | 2 | 10 | 1 | 0 | 0 | 1 | 20 |
(23/10/2022)vs
BST / NIGICO | 29 | 10 | 2 / 2100% | 4 / 944.4% | 0 / 00% | 4 / 944.4% | | 3 | 5 | 2 | 7 | 4 | 1 | 0 | 2 | 15 |
(16/10/2022)vs
NEW MED | 00 | 26 | 4 / 666.7% | 11 / 1764.7% | 0 / 00% | 11 / 1764.7% | | 4 | 8 | 4 | 12 | 1 | 1 | 0 | 2 | 30 |
(08/10/2022)vs
LP CLINIC | 23 | 11 | 1 / 250% | 5 / 771.4% | 0 / 00% | 5 / 771.4% | | 4 | 1 | 1 | 2 | 1 | 0 | 1 | 0 | 12 |
| ΣΥΝΟΛΙΚΑ |
176 |
205 |
22 / 4548.9% |
90 / 15060% |
1 / 333.3% |
91 / 15359.5% |
|
37 |
59 |
37 |
96 |
25 |
20 |
2 |
18 |
245 |
| ΜΕΣΟΙ ΟΡΟΙ |
14.7 |
17.1 |
1.8 / 3.848.9% |
7.5 / 12.560% |
0.1 / 0.233.3% |
7.6 / 12.859.5% |
|
3.1 |
4.9 |
3.1 |
8 |
2.1 |
1.7 |
0.2 |
1.5 |
20.4 |